跳至主要内容
临床试验/EUCTR2013-001407-36-AT
EUCTR2013-001407-36-AT进行中(未招募)不适用

Assessment of Hepatic Glucose Production Following Repeated Glucagon Administration in Type 1 Diabetes Patients

Medizinische Universität Graz0 个研究点开始时间: 2013年4月9日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Type 1 diabetes treated with multiple daily insulin injections or
  • continuous subcutaneous insulin infusion for 12 months
  • Male or female aged 18-65 years (both inclusive)
  • HbA1c < 10%
  • Informed consent obtained after being advised of the nature of the study
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 7
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • Pregnancy, breast-feeding, intention of becoming pregnant, or not usingadequate contraception
  • Any disease or condition which would interfere with the subject's safety
  • Skin pathology or condition prohibiting needle insertion/glucagon
  • administration as judged by the investigator
  • Severe acute deseases
  • Current participation in another clinical study
  • Uncontrolled hypertension
  • Clinically overt diabetic complications
  • Mental incapacity, unwillingness, or language barriers precluding
  • adequate understanding or cooperation
  • Taking any vasoactive substances or anticoagulatory medication
  • Use of a medication that significantly impacts glucose metabolism
  • i.e. oral ot topical steroids, except in the case of a stable state with a minimum duration of at least 3 months preceeding the study as well asunder the condition that the state remain stable for the duration of the study
  • Symptomatic coronary artery disease
  • Blood donation within 3 months preceeding the study

研究者

相似试验